Keith Byrne - Lumibird Director Systems
| LBIRD Stock | EUR 7.30 0.06 0.83% |
Insider
Keith Byrne is Director Systems of Lumibird SA
| Phone | 33 2 96 05 08 00 |
| Web | https://www.lumibird.com |
Lumibird Management Efficiency
The company has return on total asset (ROA) of 0.0281 % which means that it generated a profit of $0.0281 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0565 %, meaning that it generated $0.0565 on every $100 dollars invested by stockholders. Lumibird's management efficiency ratios could be used to measure how well Lumibird manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Christophe Arquilliere | Thermador Groupe SA | 55 | |
| Franois Feuillet | Trigano SA | 74 | |
| Eric Mantione | Thermador Groupe SA | 64 | |
| John Mackay | Sartorius Stedim Biotech | 61 | |
| Laurence Jacquot | Lectra SA | 56 | |
| Luciana Cemerka | Teleperformance SE | N/A | |
| Arlette Berliocchi | Thermador Groupe SA | 53 | |
| Fabienne Bochet | Thermador Groupe SA | 49 | |
| Maximilien Abadie | Lectra SA | 34 | |
| Leigh Ryan | Teleperformance SE | 70 | |
| Petra Kirchhoff | Sartorius Stedim Biotech | 54 | |
| Olivier Guitard | Sartorius Stedim Biotech | N/A | |
| Lionel Monroe | Thermador Groupe SA | 56 | |
| Maria Modrono | Lectra SA | N/A | |
| Cdric Ratouis | Trigano SA | 42 | |
| Michel Freiche | Trigano SA | 62 | |
| Joachim Kreuzburg | Sartorius Stedim Biotech | 58 | |
| Xavier Isaac | Thermador Groupe SA | 54 | |
| Yannis Tourcomanis | Teleperformance SE | N/A | |
| Paolo Bicci | Trigano SA | 65 | |
| Olivier Rigaudy | Teleperformance SE | 64 | |
Management Performance
| Return On Equity | 0.0565 | |||
| Return On Asset | 0.0281 |
Lumibird SA Leadership Team
Elected by the shareholders, the Lumibird's board of directors comprises two types of representatives: Lumibird inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lumibird. The board's role is to monitor Lumibird's management team and ensure that shareholders' interests are well served. Lumibird's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lumibird's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marie Lebrun, Independent Director | ||
| MarieChristine Padrutt, Director HR | ||
| Fabrice Mambro, VP Care | ||
| Keith Byrne, Director Systems | ||
| Philippe Metivier, Director of Marketing and Communication, Member of the Management Committee | ||
| Olivier Rabot, Member of the Management Committee, Aerospace and Defence | ||
| Luc Ardon, Member of the Management Committee and Chief Financial Officer | ||
| JeanFrancois Coutris, Director - Representative of ESIRA | ||
| Gwenaelle Flohic, Director - Representative of EURODYNE | ||
| Sonia Rutnam, CFO Transformation | ||
| Denis Lemercier, Director of Operations, Member of the Management Board | ||
| Patrick Maine, Member of the Management Committee | ||
| Emmanuel Cueff, Independent Director | ||
| Marc Flohic, Chairman of the Board, Chief Executive Officer, Member of the Management Committee | ||
| Aude NomblotGourhand, Gen CFO | ||
| Steve Patterson, Member of the Management Committee, Director of Quantel USA | ||
| JeanMarc Gendre, Member of the Management Committee, Director of Quantel Medical |
Lumibird Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lumibird a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0565 | |||
| Return On Asset | 0.0281 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 356.61 M | |||
| Shares Outstanding | 22.29 M | |||
| Shares Owned By Insiders | 59.55 % | |||
| Shares Owned By Institutions | 13.05 % | |||
| Price To Earning | 31.05 X | |||
| Price To Book | 1.85 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lumibird Stock Analysis
When running Lumibird's price analysis, check to measure Lumibird's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lumibird is operating at the current time. Most of Lumibird's value examination focuses on studying past and present price action to predict the probability of Lumibird's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lumibird's price. Additionally, you may evaluate how the addition of Lumibird to your portfolios can decrease your overall portfolio volatility.